Cargando…

Identifying optimal therapies in patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis

BACKGROUND: Recently, increasing literature has been reported on optimal therapies in patients with advanced hepatocellular carcinoma (HCC) and many therapeutic modalities have been proposed to improve the survival rate. However, the results are not consistent due to different research protocols, sm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhenyu, Tong, Yao, Yang, Lin, He, Xianli, Bao, Guoqiang, Du, Xilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468989/ https://www.ncbi.nlm.nih.gov/pubmed/36300147 http://dx.doi.org/10.21037/tgh-20-318

Ejemplares similares

Expression and biological significance of c-FLIP in human hepatocellular carcinomas
por: Du, Xilin, et al.
Publicado: (2009)

Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Systematic review of rectal foreign bodies in older men: humanistic care and a novel challenge for society
por: Yang, Zhenyu, et al.
Publicado: (2022)

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Association study between KCNQ1 and KCNQ1OT1 genetic polymorphisms and gastric cancer susceptibility and survival in a Chinese Han population: a case-control study
por: Yang, Zhenyu, et al.
Publicado: (2021)

A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis
por: Zhao, Shoujie, et al.
Publicado: (2020)

CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling
por: Lei, Shixiong, et al.
Publicado: (2023)

Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2015)

Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
por: Guo, Tao, et al.
Publicado: (2019)

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

ORC6, Negatively Regulated by miR-1-3p, Promotes Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells
por: Chen, Hu, et al.
Publicado: (2021)

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)

FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma
por: Lei, Shixiong, et al.
Publicado: (2016)

Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Sun, Tingting, et al.
Publicado: (2018)

EccDNA-oriented ITGB7 expression in breast cancer
por: Yang, Lin, et al.
Publicado: (2022)

Prognostic significance of CTNNB1 mutation in hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Genlin, et al.
Publicado: (2023)

Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
por: Tian, Guo, et al.
Publicado: (2018)

Recent advances in recurrent hepatocellular carcinoma therapy
por: Gao, Yu-Xue, et al.
Publicado: (2023)

Network meta-analysis of treatment regimens for inoperable advanced hepatocellular carcinoma with portal vein invasion
por: Li, Ming-Feng, et al.
Publicado: (2018)

S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature
por: Huang, Wu-kui, et al.
Publicado: (2017)

Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials
por: Wang, Dongxu, et al.
Publicado: (2020)

The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
por: Yao, Wei, et al.
Publicado: (2017)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Apatinib is effective for treatment of advanced hepatocellular carcinoma
por: Kong, Yinlong, et al.
Publicado: (2017)

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
por: Fong, Khi Yung, et al.
Publicado: (2022)

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
por: Bao, Guoqiang, et al.
Publicado: (2010)

Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis
por: Pan, Qi, et al.
Publicado: (2016)

Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology
por: Han, Yunqi, et al.
Publicado: (2023)

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network
por: Chen, Wenbiao, et al.
Publicado: (2019)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis
por: Hui, Fuhai, et al.
Publicado: (2022)

The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis
por: Zhao, Shoujie, et al.
Publicado: (2020)

Systemic therapy in advanced hepatocellular carcinoma
por: Ahn, Joseph C., et al.
Publicado: (2023)

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma
por: Li, Qingqing, et al.
Publicado: (2022)

Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
por: Gu, Xiaoying, et al.
Publicado: (2022)

Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma
por: Yang, Zhe, et al.
Publicado: (2020)

Advances in radiotherapy and immunity in hepatocellular carcinoma
por: Yang, Yuhan, et al.
Publicado: (2023)

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
por: Oranratnachai, Songporn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gfdje52en09vc0ugqgvv6kc5eu